Literature DB >> 28861153

Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation.

Nannan Pang1, Jianli Xu1, Jianhua Qu1, Xianlin Duan1, Hailong Yuan1, Gang Chen1, Ming Jiang1, Jianbing Ding2,3.   

Abstract

T helper type 9 (Th9) cells have recently been identified as a new effector T cell subset. This study is to analyze the reconstitution of Th9 cell after matched sibling peripheral blood hematopoietic stem cell transplantation (MS-PBSCT) and the relationship between Th9 cell and acute graft-versus-host disease (aGVHD). Flow cytometry and ELISA were used to analyze the percentages of Th9 cell, levels of IL-9, TGF-β, IFN-γ, and IL-4. The results showed that for patients without aGVHD, Th9 cells recovery started from day 60 after transplantation and reached normal level on day 90. Serum TGF-β, IL-4, and IFN-γ reached normal levels on day 60, 60, and 90 post transplantation respectively. The serum IL-9 recovery is slower than that of IFN-γ and IL-4. For patients suffering from aGVHD, they had declined Th9 cell numbers, lower IL-9 and TGF-β levels, but higher serum IFN-γ level when compared with those without aGVHD after transplantation. Serum IFN-γ/IL-9 ratios increased linearly with grades of aGVHD. In conclusion, Th9 cells recovery is delayed after MS-PBSCT in patients with aGVHD but early in patients without aGVHD, indicating quick immune reconstitution of Th9 cells and IL-9 after MS-PBSCT may promote the immune tolerance.

Entities:  

Keywords:  Allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT); IL-9; Th9 cells; acute graft-versus-host disease (aGVHD)

Year:  2017        PMID: 28861153      PMCID: PMC5575176     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  38 in total

1.  Immune reconstitution following allogeneic peripheral blood stem cell transplants.

Authors:  S Shenoy; T Mohanakumar; G Todd; W Westhoff; K Dunnigan; D R Adkins; R A Brown; J F DiPersio
Journal:  Bone Marrow Transplant       Date:  1999-02       Impact factor: 5.483

2.  Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21.

Authors:  Cindy S Ma; Stuart G Tangye; Elissa K Deenick
Journal:  Immunol Cell Biol       Date:  2010-06-08       Impact factor: 5.126

3.  Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells.

Authors:  Raewyn Broady; Jie Yu; Vickie Chow; Adisak Tantiworawit; Christine Kang; Kyra Berg; Magdalena Martinka; Mehran Ghoreishi; Jan Dutz; Megan K Levings
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

4.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

5.  Intragraft cytokine expression and tolerance induction in rat renal allografts.

Authors:  B H Saggi; R A Fisher; D Bu; J W Tawes; R Riley; M P Posner
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

6.  Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.

Authors:  Dao-Pei Lu; Lujia Dong; Tong Wu; Xiao-Jun Huang; Mei-Jie Zhang; Wei Han; Huan Chen; Dai-Hong Liu; Zhi-Yong Gao; Yu-Hong Chen; Lan-Ping Xu; Yao-Chen Zhang; Han-Yun Ren; Dan Li; Kai-Yan Liu
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

Review 7.  Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies.

Authors:  Feras Alfraih; Mahmoud Aljurf; Courtney D Fitzhugh; Adetola A Kassim
Journal:  Semin Hematol       Date:  2016-01-15       Impact factor: 3.851

8.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

9.  Th9/IL-9 profile in human echinococcosis: their involvement in immune response during infection by Echinococcus granulosus.

Authors:  Nannan Pang; Fengbo Zhang; Xiumin Ma; Zhaoxia Zhang; Hui Zhao; Yan Xin; Song Wang; Yuejie Zhu; Hao Wen; Jianbing Ding
Journal:  Mediators Inflamm       Date:  2014-03-30       Impact factor: 4.711

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  2 in total

1.  In vitro-generated alloantigen-specific Th9 cells mediate antileukemia cytotoxicity in the absence of graft-versus-host disease.

Authors:  Tanja Reisser; Daniel Halbgebauer; Jasmin Scheurer; Linda Wolf; Frank Leithäuser; Niklas Beyersdorf; Pamela Fischer-Posovszky; Klaus-Michael Debatin; Gudrun Strauss
Journal:  Leukemia       Date:  2020-02-07       Impact factor: 11.528

Review 2.  Protein dysregulation in graft versus host disease.

Authors:  Liren Qian; Delia Dima; Cristian Berce; Yu Liu; Ioana Rus; Lajos-Zsolt Raduly; Yi Liu; Bobe Petrushev; Ioana Berindan-Neagoe; Alexandru Irimie; Alina Tanase; Ancuta Jurj; Jianliang Shen; Ciprian Tomuleasa
Journal:  Oncotarget       Date:  2017-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.